Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
UK's budget deficit in February reaches 14.3 billion pounds, far exceeding expectations

UK's budget deficit in February reaches 14.3 billion pounds, far exceeding expectations

金十金十2026/03/20 07:42
Show original
Golden Ten Data reported on March 20 that the UK’s budget deficit in February exceeded expectations, highlighting the risks facing the country’s public finances—even before the Iran war fundamentally altered the economic outlook. According to the UK Office for National Statistics, government spending in February surpassed tax revenue by £14.3 billion (equivalent to $19.2 billion). This figure is higher than economists’ forecast of £8.8 billion and is twice the amount predicted by the UK Office for Budget Responsibility in November, marking the second-highest deficit for the month on record. The widening deficit is attributed to rising debt interest costs, as well as increased spending on public services and welfare. The £10.8 billion increase in spending outpaced the £8.6 billion rise in tax revenue. Now, the energy price shock triggered by the Middle East war may further derail the UK’s public finances. This crisis has already caused the UK government’s borrowing costs to soar, raised concerns about a resurgence in unemployment, and prompted calls for the government to support struggling households. This may make it difficult for Chancellor Reeves to fulfill her balanced budget mandate and could have an impact on financial markets.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.

Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.

智通财经•2026/10/09 07:09

Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.

Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.

智通财经•2026/10/09 07:08

Pimco warns: 10-year US Treasury yield may hit 6%, for the first time since 2000

PIMCO's Chief Investment Officer stated that due to high oil prices intensifying inflation concerns and market unease over the growing U.S. public debt, the benchmark 10-year U.S. Treasury yield could rise to 6% for the first time since 2000.

智通财经•2026/10/09 06:47